NPPB and heart failure: Thus far, clinical trials have identified both benefits and risks of synthetic ANP (anaritide, carperitide) and BNP (nesiritide) for treating hypertension, renal insufficiency, and heart failure in humans; however, these drugs have not yet joined the mainstream of therapeutic treatments in the US [164,165,166].